Back to Agenda
Meeting in the Middle: Best Practices for Collaboration Between Medical Affairs and Clinical Development
Session Chair(s)
J. Lynn Bass, PharmD, RPh
Senior Director, Medical Science Liaisons
BridgeBio, United States
Medical affairs and clinical development enhance the scientific credibility of the company (and its products) with established and emerging clinical investigators These collaborations may also improve study recruitment techniques.
Learning Objective : Design new activities which require participation from both medical affairs and clinical development; Demonstrate how the medical affairs team can provide real-world data to help inform study designs and execution; Critique case studies of successful collaborations.
Speaker(s)
Industry Update
J. Lynn Bass, PharmD, RPh
BridgeBio, United States
Senior Director, Medical Science Liaisons
Industry Update
Rebecca A. Vermeulen, RPh
Genentech, A Member of the Roche Group, United States
Vice President, Global Patient Networks | PD Medical Affairs
Industry Update
Sonja Hokett, PharmD, MS, MSc
BioXcel Therapeutics, United States
Executive Director, Medical Managed Care & HEOR
Have an account?